SCHEMBL320155

SCHEMBL320155

CC(C)C(N)C(=O)OC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 2/20 0.46
NOS3 P29474 1/20 0.46
NOS2 P35228 1/20 0.46
SLC7A5 Q01650 1/20 0.44
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA12 O43570 1/20 0.34
CA14 Q9ULX7 1/20 0.34
DPP4 P27487 3/20 0.33
CYP2D6 P10635 2/20 0.33
LMNA P02545 2/20 0.33
KMT2A Q03164 1/20 0.33
DGAT1 O75907 1/20 0.33
FAP Q12884 1/20 0.33
DPP8 Q6V1X1 1/20 0.33
DPP9 Q86TI2 1/20 0.33
DPP7 Q9UHL4 1/20 0.33
LAP3 P28838 1/20 0.32
CYP3A4 P08684 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL919727 1.00 NOS1 (0.46) NOS1NOS3NOS2SLC7A5CA1
SCHEMBL311871 1.00 NOS1 (0.46) NOS1NOS3NOS2SLC7A5CA1
Hydrochloric Acid SCHEMBL919725 0.98 NOS1 (0.45) NOS1NOS3NOS2SLC7A5CA1
Hydrochloric Acid SCHEMBL146833 0.98 NOS1 (0.45) NOS1NOS3NOS2SLC7A5CA1
Hydrochloric Acid SCHEMBL146832 0.98 NOS1 (0.45) NOS1NOS3NOS2SLC7A5CA1
Trifluoroacetic Acid SCHEMBL28911781 0.88 NOS1 (0.40) NOS1NOS3NOS2SLC7A5CA1
Trifluoroacetic Acid SCHEMBL28911780 0.88 NOS1 (0.40) NOS1NOS3NOS2SLC7A5CA1
SCHEMBL28062530 0.87 NOS1 (0.46) NOS1NOS3NOS2SLC7A5CA1
SCHEMBL6565617 0.86 NOS1 (0.46) NOS1NOS3NOS2SLC7A5CA1
SCHEMBL31107708 0.86 NOS1 (0.46) NOS1NOS3NOS2SLC7A5CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 397 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119470406-A Phthalic dicarboxaldehyde disinfectant concentration detection test paper and preparation method thereof 山东新华莎罗雅生物技术有限公司 2025-02-18 CN claimed
US-5763614-A VASODILATION BASED ON CALCIUM ANTAGONISM AND PAF ANTAGONISM FUJIREBIO INC. (JP) 1998-06-09 US claimed
US-5696268-A REACTING N-ACYLAMINO ACID DERIVATIVE WITH OPTICALLY ACTIVE ENAMINE DERIVATIVE, REACTING PRODUCT WITH AMMONIA OR AMMONIUM SALT FUJIREBIO INC. (JP) 1997-12-09 US claimed
US-5644059-A REACTION OF KETONE WITH ACRYLAMIDE AND AMMONIA OR AMMONIUM SALT FUJIREBIO INC. (JP) 1997-07-01 US claimed
EP-0488345-A1 1,4-Dihydropyridine derivatives and methods of producing the same FUJIREBIO INC. (JP) 1992-06-03 EP claimed
US-12600699-B2 Thiosemicarbazates and uses thereof THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2026-04-14 US disclosed
US-12595233-B2 Thiosemicarbazates and uses thereof THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2026-04-07 US disclosed
US-12441760-B2 Amino diacids containing peptide modifiers CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S.A. (GR) 2025-10-14 US disclosed
US-20250304603-A1 OXABOROLE ESTERS AND USES THEREOF ANACOR PHARMACEUTICALS INC (US) 2025-10-02 US disclosed
EP-4552498-A1 METHOD FOR PREVENTING INSECT DAMAGE TO PLANTS AJINOMOTO CO., INC. (JP) 2025-05-14 EP disclosed
US-20250127166-A1 METHOD FOR PREVENTING INSECT DAMAGE TO PLANTS AJINOMOTO CO., INC. (JP) 2025-04-24 US disclosed
CN-119546186-A Method for controlling insect pests of plants 味之素株式会社 2025-02-28 CN disclosed
WO-1997024369-A1 GROWTH-HORMONE SECRETAGOGUES PFIZER INC. (US) 1997-07-10 WO disclosed
US-5644059-A REACTION OF KETONE WITH ACRYLAMIDE AND AMMONIA OR AMMONIUM SALT FUJIREBIO INC. (JP) 1997-07-01 US disclosed
WO-1997021683-A1 RETROVIRAL PROTEASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1997-06-19 WO disclosed
EP-0658169-A1 DIAMINO ACID DERIVATIVES AS ANTIHYPERTENSIVES SCHERING CORPORATION (US) 1995-06-21 EP disclosed
US-5367081-A Vasodilator, antiallergen FUJIREBIO INC. (JP) 1994-11-22 US disclosed
US-5298492-A Inhibitors of endopeptidase and treatment of cardiovascular disorders SCHERING CORPORATION (US) 1994-03-29 US disclosed
WO-1994003481-A1 DIAMINO ACID DERIVATIVES AS ANTIHYPERTENSIVES SCHERING CORPORATION (US) 1994-02-17 WO disclosed
EP-0488345-A1 1,4-Dihydropyridine derivatives and methods of producing the same FUJIREBIO INC. (JP) 1992-06-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12441760-B2 Amino diacids containing peptide modifiers PTMS, PEPD, NGLY1 NOS1 1007/4885NOS3 1680/4885NOS2 1974/4885
US-20250304603-A1 OXABOROLE ESTERS AND USES THEREOF OXA1L, HSD17B12, OXER1 NOS1 2432/4885NOS3 1730/4885NOS2 1726/4885
US-20250127166-A1 METHOD FOR PREVENTING INSECT DAMAGE TO PLANTS GGT1, GGH, CAT NOS1 1158/4885NOS3 645/4885NOS2 1159/4885
US-12595233-B2 Thiosemicarbazates and uses thereof TST, THRB, HSPB1 NOS1 1979/4885NOS3 2374/4885NOS2 2850/4885
US-12600699-B2 Thiosemicarbazates and uses thereof MET, THRB, ABAT NOS1 828/4885NOS3 1235/4885NOS2 1000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.